In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
Session

Event : ESC Congress 2015

Topic : Acute Coronary Syndromes – Pathophysiology and Mechanisms

  • Session type : EBAC Accredited Educational Programme - Experts on the Spot
  • Date : 01 September 2015
  • Time : 10:15 - 10:45
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

4 presentations in this session

Welcome and introduction - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Clinical case study – Optimal duration of dual antiplatelet therapy.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Open questions - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB), C Hamm (Bad Nauheim,DE)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Close - Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence.

Event : ESC Congress 2015

  • Session : Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence
  • Speaker : K Fox (Edinburgh,GB)
  • Organised by University Hospital of Umea Course Director: Ulf Naslund Supported by an unrestricted educational grant from AstraZeneca

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are